Singapore Exchange divests Scientific Beta to STOXX

SGX Filings
07/08

On Jul, 8 2026, Singapore Exchange (S68) announced the sale of its wholly owned subsidiary, Scientific Beta, to STOXX Ltd.

The transaction is part of SGX Group’s strategy of active portfolio management and capital allocation, allowing the bourse operator to redirect resources toward areas that reinforce its multi-asset franchise in securities, derivatives and data.

SGX Group said it will retain its global multi-asset iEdge platform and continue to expand its index business as a core component of its wider offering.

Head of Global Financial Markets Ng Yao Loong stated that the divestment will enable SGX Group to concentrate on opportunities with the greatest potential impact for clients, partners and shareholders while positioning Scientific Beta for its next phase of growth under new ownership.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10